Return to homepagePandemic Pact

COVID-19 in patients with HEART FAILURE AND FAMILY HEART DISEASE

  • Funded by National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)
  • Total publications:0 publications

Grant number: COV20_00420

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Funder

    National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)

  • Principal Investigator

    Juan Ramón Gimeno Blanes

  • Research Location

    Spain

  • Lead Research Institution

    FUNDACION PARA LA FORMACION E INVESTIGACION SANITARIAS DE LA REGION DE MURCIA (FFIS)

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Disease pathogenesis

  • Special Interest Tags

    Data Management and Data Sharing

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

An online platform will be created to register cases of patients with previous heart failure or familial heart disease in which CoViD19 infection is confirmed. It will be an anonymized record that will be accessed with a username and password through the Web and will include basic demographic data, previous diagnoses, symptoms, previous and during the episode treatments, necessary interventions during admission and events. A common database will be generated from which the grouped data can be viewed and the corresponding statistical analyzes performed. The data will be available from the beginning of the project for the health authorities and for the participants in the registry. The registry will remain active for at least 2 years to be able to collect data retrospectively from patients undergoing previous follow-up in consultations, and for the incorporation of information on evolution and complications in the short and medium term.